Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria

Molecular Genetics and Metabolism

Volumn 100, Issue 4, 2010, Pages 303-308

  MacLeod, Erin L ^a   Clayton, Murray K ^a   van Calcar, Sandra C ^b   Ney, Denise M ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

GMP; Hunger; Insulin; PKU; Satiety

Indexed keywords

AMINO ACID; GHRELIN; GLYCOPROTEIN; HISTIDINE; INSULIN; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE; CASEIN; CASEINOMACROPEPTIDE; PEPTIDE FRAGMENT;

ABSORPTION; ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGRADATION; DIET SUPPLEMENTATION; FEMALE; FOOD; FOOD INTAKE; HOSPITAL PATIENT; HUMAN; INSULIN BLOOD LEVEL; MALE; MEAL; PHENYLKETONURIA; POSTPRANDIAL STATE; PRIORITY JOURNAL; SATIETY; SCHOOL CHILD; VISUAL ANALOG SCALE; BLOOD; DIET; DIET THERAPY; DRUG EFFECTS; MOTIVATION; PAIN MEASUREMENT; PSYCHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AMINO ACIDS; CASEINS; CHILD; DIET; FEMALE; FOOD; GHRELIN; HUMANS; INSULIN; MALE; MOTIVATION; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; PHENYLKETONURIAS; POSTPRANDIAL PERIOD; SATIETY RESPONSE; YOUNG ADULT;

EID: 77954229363     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2010.04.003     Document Type: Article

References (48)

1. Donlon J., Levy H., Scriver C. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. Metabolic and Molecular Basis of Inherited Disease 2007, McGraw-Hill, (Chapter 77). C. Scriver, A. Beaudet, W. Sly, D. Valle (Eds.).
2. Koch R., Burton B., Hoganson G., Peterson R., Rhead W., Rouse B., Scott R., Wolff J., Stern A.M., Guttler F., Nelson M., de la Cruz F., Coldwell J., Erbe R., Geraghty M.T., Shear C., Thomas J., Azen C. Phenylketonuria in adulthood: a collaborative study. J. Inherit. Metab. Dis. 2002, 25:333-346.
3. NIH, phenylketonuria (PKU): screening and management, NIH consensus statement, 17 (2000) 1-33.
4. van Spronsen F.J., Ahring K.K., Gizewska M. PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European society of phenylketonuria and allied disorders. J. Inherit. Metab. Dis. 2009, 32:58-64.
5. MacDonald A., Rylance G., Davies P., Asplin D., Hall S.K., Booth I.W. Administration of protein substitute and quality of control in phenylketonuria: a randomized study. J. Inherit. Metab. Dis. 2003, 26:319-326.
6. Monch E., Herrmann M.E., Brosicke H., Schoffer A., Keller M. Utilisation of amino acid mixtures in adolescents with phenylketonuria. Eur. J. Pediatr. 1996, 155(Suppl. 1):S115-S120.
7. Weigle D.S., Breen P.A., Matthys C.C., Callahan H.S., Meeuws K.E., Burden V.R., Purnell J.Q. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am. J. Clin. Nutr. 2005, 82:41-48.
8. Westerterp-Plantenga M.S., Rolland V., Wilson S.A., Westerterp K.R. Satiety related to 24h diet-induced thermogenesis during high protein/carbohydrate vs high fat diets measured in a respiration chamber. Eur. J. Clin. Nutr. 1999, 53:495-502.
9. Millward D.J., Layman D.K., Tome D., Schaafsma G. Protein quality assessment: impact of expanding understanding of protein and amino acid needs for optimal health. Am. J. Clin. Nutr. 2008, 87:1576S-1581S.
10. Veldhorst M.A., Nieuwenhuizen A.G., Hochstenbach-Waelen A., van Vught A.J., Westerterp K.R., Engelen M.P., Brummer R.J., Deutz N.E., Westerterp-Plantenga M.S. Dose-dependent satiating effect of whey relative to casein or soy. Physiol. Behav. 2009, 96:675-682.
11. Hall W.L., Millward D.J., Long S.J., Morgan L.M. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br. J. Nutr. 2003, 89:239-248.
12. Anderson G.H., Tecimer S.N., Shah D., Zafar T.A. Protein source, quantity, and time of consumption determine the effect of proteins on short-term food intake in young men. J. Nutr. 2004, 134:3011-3015.
13. Etzel M.R. Manufacture and use of dairy protein fractions. J. Nutr. 2004, 134:996S-1002S.
14. Matalon R., Michals-Matalon K., Bhatia G., Burlina A.B., Burlina A.P., Braga C., Fiori L., Giovannini M., Grechanina E., Novikov P., Grady J., Tyring S.K., Guttler F. Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine. J. Inherit. Metab. Dis. 2007, 30:153-158.
15. Luhovyy B.L., Akhavan T., Anderson G.H. Whey proteins in the regulation of food intake and satiety. J. Am. Coll. Nutr. 2007, 26:704S-712S.
16. Brody E.P. Biological activities of bovine glycomacropeptide. Br. J. Nutr. 2000, 84(Suppl. 1):S39-S46.
17. Burton-Freeman B.M. Glycomacropeptide (GMP) is not critical to whey-induced satiety, but may have a unique role in energy intake regulation through cholecystokinin (CCK). Physiol. Behav. 2008, 93:379-387.
18. Lam S.M., Moughan P.J., Awati A., Morton H.R. The influence of whey protein and glycomacropeptide on satiety in adult humans. Physiol. Behav. 2009, 96:162-168.
19. Gustafson D.R., McMahon D.J., Morrey J., Nan R. Appetite is not influenced by a unique milk peptide: caseinomacropeptide (CMP). Appetite 2001, 36:157-163.
20. Keogh J.B., Clifton P. The effect of meal replacements high in glycomacropeptide on weight loss and markers of cardiovascular disease risk. Am. J. Clin. Nutr. 2008, 87:1602-1605.
21. Veldhorst M.A., Nieuwenhuizen A.G., Hochstenbach-Waelen A., Westerterp K.R., Engelen M.P., Brummer R.J., Deutz N.E., Westerterp-Plantenga M.S. Effects of complete whey-protein breakfasts versus whey without GMP-breakfasts on energy intake and satiety. Appetite 2009, 52:388-395.
22. Strader A.D., Woods S.C. Gastrointestinal hormones and food intake. Gastroenterology 2005, 128:175-191.
23. Lee H.M., Wang G., Englander E.W., Kojima M., Greeley G.H. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002, 143:185-190.
24. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
25. Callahan H.S., Cummings D.E., Pepe M.S., Breen P.A., Matthys C.C., Weigle D.S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J. Clin. Endocrinol. Metab. 2004, 89:1319-1324.
26. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., Purnell J.Q. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 2002, 346:1623-1630.
27. Schulpis K.H., Papassotiriou I., Vounatsou M., Karikas G.A., Tsakiris S., Chrousos G.P. Morning preprandial plasma ghrelin and catecholamine concentrations in patients with phenylketonuria and normal controls: evidence for catecholamine-mediated ghrelin regulation. J. Clin. Endocrinol. Metab. 2004, 89:3983-3987.
28. van Calcar S.C., MacLeod E.L., Gleason S.T., Etzel M.R., Clayton M.K., Wolff J.A., Ney D.M. Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids. Am. J. Clin. Nutr. 2009, 89:1068-1077.
29. Ney D.M., Gleason S.T., van Calcar S.C., MacLeod E.L., Nelson K.L., Etzel M.R., Rice G.M., Wolff J.A. Nutritional management of PKU with glycomacropeptide from cheese whey. J. Inherit. Metab. Dis. 2009, 32:32-39.
30. Lim K., van Calcar S.C., Nelson K.L., Gleason S.T., Ney D.M. Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU. Mol. Genet. Metab. 2007, 92:176-178.
31. Laclair C.E., Ney D.M., MacLeod E.L., Etzel M.R. Purification and use of glycomacropeptide for nutritional management of phenylketonuria. J. Food Sci. 2009, 74:E199-E206.
32. Slocum R.H., Cummings J.G. Amino acid analysis of physiological samples. Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual 1991, 87-126. Wiley-Liss, New York. F.A. Hommes (Ed.).
33. Stubbs R.J., Hughes D.A., Johnstone A.M., Rowley E., Reid C., Elia M., Stratton R., Delargy H., King N., Blundell J.E. The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br. J. Nutr. 2000, 84:405-415.
34. Anderson G.H., Catherine N.L., Woodend D.M., Wolever T.M. Inverse association between the effect of carbohydrates on blood glucose and subsequent short-term food intake in young men. Am. J. Clin. Nutr. 2002, 76:1023-1030.
35. Darling P.B., Grunow J., Rafii M., Brookes S., Ball R.O., Pencharz P.B. Threonine dehydrogenase is a minor degradative pathway of threonine catabolism in adult humans. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E877-E884.
36. Modan-Moses D., Vered I., Schwartz G., Anikster Y., Abraham S., Segev R., Efrati O. Peak bone mass in patients with phenylketonuria. J. Inherit. Metab. Dis. 2007, 30:202-208.
37. Cummings D.E. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol. Behav. 2006, 89:71-84.
38. Foster-Schubert K.E., Overduin J., Prudom C.E., Liu J., Callahan H.S., Gaylinn B.D., Thorner M.O., Cummings D.E. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J. Clin. Endocrinol. Metab. 2008, 93:1971-1979.
39. Lejeune M.P., Westerterp K.R., Adam T.C., Luscombe-Marsh N.D., Westerterp-Plantenga M.S. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am. J. Clin. Nutr. 2006, 83:89-94.
40. Overduin J., Frayo R.S., Grill H.J., Kaplan J.M., Cummings D.E. Role of the duodenum and macronutrient type in ghrelin regulation. Endocrinology 2005, 146:845-850.
41. Gropper S.S., Acosta P.B. Effect of simultaneous ingestion of l-amino acids and whole protein on plasma amino acid and urea nitrogen concentrations in humans. JPEN J. Parenter. Enteral. Nutr. 1991, 15:48-53.
42. Deglaire A., Fromentin C., Fouillet H., Airinei G., Gaudichon C., Boutry C., Benamouzig R., Moughan P.J., Tome D., Bos C. Hydrolyzed dietary casein as compared with the intact protein reduces postprandial peripheral, but not whole-body, uptake of nitrogen in humans. Am. J. Clin. Nutr. 2009, 90:1011-1022.
43. Daenzer M., Petzke K.J., Bequette B.J., Metges C.C. Whole-body nitrogen and splanchnic amino acid metabolism differ in rats fed mixed diets containing casein or its corresponding amino acid mixture. J. Nutr. 2001, 131:1965-1972.
44. Tome D., Schwarz J., Darcel N., Fromentin G. Protein, amino acids, vagus nerve signaling, and the brain. Am. J. Clin. Nutr. 2009, 90:838S-843S.
45. Mellinkoff S.M., Frankland M., Boyle D., Greipel M. Relationship between serum amino acid concentration and fluctuations in appetite. 1956. Obes. Res. 1997, 5:381-384.
46. Williams D.L., Cummings D.E., Grill H.J., Kaplan J.M. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology 2003, 144:2765-2767.
47. Weigel C., Rauh M., Kiener C., Rascher W., Knerr I. Effects of various dietary amino acid preparations for phenylketonuric patients on the metabolic profiles along with postprandial insulin and ghrelin responses. Ann. Nutr. Metab. 2007, 51:352-358.
48. Schmid R., Schulte-Frohlinde E., Schusdziarra V., Neubauer J., Stegmann M., Maier V., Classen M. Contribution of postprandial amino acid levels to stimulation of insulin, glucagon, and pancreatic polypeptide in humans. Pancreas 1992, 7:698-704.